Hereditary Angioedema: The Economics of Treatment of an Orphan Disease

This review will discuss the cost burden of hereditary angioedema on patients, healthcare systems, and society. The impact of availability of and access to novel and specific therapies on morbidity, mortality, and the overall burden of disease will be explored along with potential changes in treatme...

Descripción completa

Detalles Bibliográficos
Autor principal: Lumry, William Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820358/
https://www.ncbi.nlm.nih.gov/pubmed/29503818
http://dx.doi.org/10.3389/fmed.2018.00022
_version_ 1783301349827411968
author Lumry, William Raymond
author_facet Lumry, William Raymond
author_sort Lumry, William Raymond
collection PubMed
description This review will discuss the cost burden of hereditary angioedema on patients, healthcare systems, and society. The impact of availability of and access to novel and specific therapies on morbidity, mortality, and the overall burden of disease will be explored along with potential changes in treatment paradigms to improve effectiveness and reduce cost of treatment. The prevalence of orphan diseases, legislative incentives to encourage development of orphan disease therapies and the impact of orphan disease treatment on healthcare payment systems will be discussed.
format Online
Article
Text
id pubmed-5820358
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58203582018-03-02 Hereditary Angioedema: The Economics of Treatment of an Orphan Disease Lumry, William Raymond Front Med (Lausanne) Medicine This review will discuss the cost burden of hereditary angioedema on patients, healthcare systems, and society. The impact of availability of and access to novel and specific therapies on morbidity, mortality, and the overall burden of disease will be explored along with potential changes in treatment paradigms to improve effectiveness and reduce cost of treatment. The prevalence of orphan diseases, legislative incentives to encourage development of orphan disease therapies and the impact of orphan disease treatment on healthcare payment systems will be discussed. Frontiers Media S.A. 2018-02-16 /pmc/articles/PMC5820358/ /pubmed/29503818 http://dx.doi.org/10.3389/fmed.2018.00022 Text en Copyright © 2018 Lumry. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Lumry, William Raymond
Hereditary Angioedema: The Economics of Treatment of an Orphan Disease
title Hereditary Angioedema: The Economics of Treatment of an Orphan Disease
title_full Hereditary Angioedema: The Economics of Treatment of an Orphan Disease
title_fullStr Hereditary Angioedema: The Economics of Treatment of an Orphan Disease
title_full_unstemmed Hereditary Angioedema: The Economics of Treatment of an Orphan Disease
title_short Hereditary Angioedema: The Economics of Treatment of an Orphan Disease
title_sort hereditary angioedema: the economics of treatment of an orphan disease
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820358/
https://www.ncbi.nlm.nih.gov/pubmed/29503818
http://dx.doi.org/10.3389/fmed.2018.00022
work_keys_str_mv AT lumrywilliamraymond hereditaryangioedematheeconomicsoftreatmentofanorphandisease

Ejemplares similares